330 related articles for article (PubMed ID: 30474817)
21. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
23. Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production.
Hsieh CC; Huang YS
PLoS One; 2016; 11(1):e0147161. PubMed ID: 26794215
[TBL] [Abstract][Full Text] [Related]
24. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
[TBL] [Abstract][Full Text] [Related]
25. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
26. Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.
Triantafillu UL; Park S; Klaassen NL; Raddatz AD; Kim Y
Int J Oncol; 2017 Mar; 50(3):993-1001. PubMed ID: 28197635
[TBL] [Abstract][Full Text] [Related]
27. Autocrine Fibronectin Inhibits Breast Cancer Metastasis.
Shinde A; Libring S; Alpsoy A; Abdullah A; Schaber JA; Solorio L; Wendt MK
Mol Cancer Res; 2018 Oct; 16(10):1579-1589. PubMed ID: 29934326
[TBL] [Abstract][Full Text] [Related]
28. Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression.
Yang D; Li Y; Xing L; Tan Y; Sun J; Zeng B; Xiang T; Tan J; Ren G; Wang Y
Cell Commun Signal; 2018 Jun; 16(1):32. PubMed ID: 29914512
[TBL] [Abstract][Full Text] [Related]
29. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S
Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154
[TBL] [Abstract][Full Text] [Related]
30. Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4.
Nie J; Zhang J; Wang L; Lu L; Yuan Q; An F; Zhang S; Jiao Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):183. PubMed ID: 29237483
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of BMP9 on breast cancer cells by regulating their interaction with pre-adipocytes/adipocytes.
Wang T; Zhang Z; Wang K; Wang J; Jiang Y; Xia J; Gou L; Liu M; Zhou L; He T; Zhang Y
Oncotarget; 2017 May; 8(22):35890-35901. PubMed ID: 28415788
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide analysis reveals miR-3184-5p and miR-181c-3p as a critical regulator for adipocytes-associated breast cancer.
Rajarajan D; Selvarajan S; Charan Raja MR; Kar Mahapatra S; Kasiappan R
J Cell Physiol; 2019 Aug; 234(10):17959-17974. PubMed ID: 30847933
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cell‑derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway.
Zhou X; Li T; Chen Y; Zhang N; Wang P; Liang Y; Long M; Liu H; Mao J; Liu Q; Sun X; Chen H
Int J Oncol; 2019 May; 54(5):1843-1852. PubMed ID: 30864702
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells.
Gyamfi J; Lee YH; Eom M; Choi J
Sci Rep; 2018 Jun; 8(1):8859. PubMed ID: 29891854
[TBL] [Abstract][Full Text] [Related]
36. [Effect of mesenchymal stem cells on the apoptosis of breast cancer cells induced by cisplatin].
Xu HT; Zhou Y; Li W; Zhang HH; Wu HY; Yang J
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):566-572. PubMed ID: 28835077
[No Abstract] [Full Text] [Related]
37. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
[TBL] [Abstract][Full Text] [Related]
38. Human breast adipose tissue: characterization of factors that change during tumor progression in human breast cancer.
Fletcher SJ; Sacca PA; Pistone-Creydt M; Coló FA; Serra MF; Santino FE; Sasso CV; Lopez-Fontana CM; Carón RW; Calvo JC; Pistone-Creydt V
J Exp Clin Cancer Res; 2017 Feb; 36(1):26. PubMed ID: 28173833
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
40. Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism.
Lee J; Hong BS; Ryu HS; Lee HB; Lee M; Park IA; Kim J; Han W; Noh DY; Moon HG
PLoS One; 2017; 12(3):e0174126. PubMed ID: 28333977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
